Home
Conditions
B-Cell Non-Hodgkin Lymphoma

Clinical trial condition

B-Cell Non-Hodgkin Lymphoma

Explore clinical trials studying B-Cell Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

40 public trials 15 recruiting studies

Refine in advanced search Browse all conditions

B-Cell Non-Hodgkin Lymphoma trial results

Recruiting

A Clinical Study of SHR-3079 in B-cell Non-Hodgkin Lymphoma

NCT07661537

Conditions: B-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies

NCT07220616

Conditions: B-Cell Non-Hodgkin Lymphoma, Hematologic Diseases, Hematologic Neoplasms, +12 more
Locations: Research Site New York, United States

Research Site Lille, France

Research Site Pierre-Bénite, France

Research Site Nagoya, Japan

View Trial Details

Recruiting

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

NCT07123454

Conditions: B-Cell Non-Hodgkin Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +12 more
Locations: Research Site Irvine, California, United States

Research Site Jacksonville, Florida, United States

Research Site Rochester, Minnesota, United States

Research Site New York, United States

View all 22 locations

View Trial Details

Recruiting

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

NCT03017820

Conditions: B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Bone Marrow Diseases, +46 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies

NCT06879340

Conditions: B-Cell Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +16 more
Locations: University of Kansas Cancer Center Westwood, Kansas, United States

View Trial Details

Recruiting

Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma

NCT07097363

Conditions: B-Cell Non-Hodgkin Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

NCT05432635

Conditions: B-Cell Non-Hodgkin Lymphoma, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +17 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies

NCT06191887

Conditions: B-Cell Non-Hodgkin Lymphoma, Chronic Disease, Disease Attributes, +35 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Recruiting

A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG11001 )

NCT07053670

Conditions: B-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology Wuhang, Hubei, China

View Trial Details

Recruiting

Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study

NCT06052826

Conditions: B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +17 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

B-Cell Non-Hodgkin Lymphoma

B-Cell Non-Hodgkin Lymphoma trial results

Related conditions